Clinical Therapeutics

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Therapeutics is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,210 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1879-114X · 0149-2918
Country
United States
Access
Not open access / not declared
Declared publication charge
4,210 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1980-01-01
  • PUBMED · 2014-01-01
Indexing
MEDLINE · PUBMED
APC
4,210 USD
Declared review time (DOAJ)
—
Actual review time (measured)
106 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

8704

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

173

i10-index

4083

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
65%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
7706726
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmacogenetics and Drug Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical studies and practices
  • Diabetes Treatment and Management
  • Pharmaceutical Economics and Policy
  • Diabetes Treatment and Management
Show all subjects (75)
  • Diabetes Treatment and Management
  • Pharmacovigilance and Adverse Drug Reactions
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmaceutical Practices and Patient Outcomes
  • Diabetes Management and Research
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Statistical Methods in Clinical Trials
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacy and Medical Practices
  • Blood Pressure and Hypertension Studies
  • Blood Pressure and Hypertension Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Lysosomal Storage Disorders Research
  • Pain Management and Opioid Use
  • Diabetes Management and Research
  • Diabetes Management and Research
  • Antibiotic Use and Resistance
  • Lysosomal Storage Disorders Research
  • Pharmacogenetics and Drug Metabolism
  • Lysosomal Storage Disorders Research
  • Pharmacogenetics and Drug Metabolism
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Anesthesia and Pain Management
  • Medication Adherence and Compliance
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Glycogen Storage Diseases and Myoclonus
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Inflammatory mediators and NSAID effects
  • Inflammatory mediators and NSAID effects
  • Pharmaceutical industry and healthcare
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Healthcare Policy and Management
  • Educational Robotics and Engineering
  • Biosimilars and Bioanalytical Methods
  • Educational Robotics and Engineering
  • Biosimilars and Bioanalytical Methods
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Pneumonia and Respiratory Infections
  • Biosimilars and Bioanalytical Methods
  • Pneumonia and Respiratory Infections
  • Schizophrenia research and treatment
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Heart Failure Treatment and Management
  • Heart Failure Treatment and Management

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: